Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.17 USD | -2.16% | -3.35% | +18.73% |
05-22 | Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635 | MT |
05-22 | Neuraxis, Inc. Provides Earnings Guidance for Late 2024 and 2025 | CI |
Business Summary
Number of employees: 19
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Neuromodulation Devices
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -8.37% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -8.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gary Peterson
FOU | Founder | - | 31/12/10 |
Brian Carrico
CEO | Chief Executive Officer | 42 | 31/12/11 |
Timothy Henrichs
DFI | Director of Finance/CFO | 51 | 02-04 |
Adrian Miranda
CTO | Chief Tech/Sci/R&D Officer | 54 | 31/12/17 |
Tom Carrico
CMP | Compliance Officer | 67 | 31/01/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Carrico
CEO | Chief Executive Officer | 42 | 31/12/11 |
Founder | 70 | 31/12/10 | |
Tom Carrico
CMP | Compliance Officer | 67 | 31/01/12 |
Beth Keyser
BRD | Director/Board Member | 55 | - |
Adrian Miranda
CTO | Chief Tech/Sci/R&D Officer | 54 | 31/12/17 |
Bradley Watkins
BRD | Director/Board Member | 49 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,647,960 | 3,368,652 ( 50.67 %) | 0 | 50.67 % |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.73% | 21.37M | |
+75.69% | 12.57B | |
-25.24% | 7.34B | |
+9.42% | 6.61B | |
+18.48% | 5.39B | |
-16.21% | 4.84B | |
+17.14% | 4.53B | |
-22.63% | 3.91B | |
-22.54% | 2.91B | |
+60.01% | 2.37B |
- Stock Market
- Equities
- NRXS Stock
- Company NeurAxis, Inc.